Medirom Healthcare Technologies Inc. Reports Strong July 2025 KPIs with High Sales Per Customer and Increased App Users

Reuters
2025/08/20
Medirom Healthcare Technologies Inc. Reports Strong July 2025 KPIs with High Sales Per Customer and Increased App Users

MEDIROM Healthcare Technologies Inc., a holistic healthcare company based in Japan and listed on Nasdaq, has reported its key performance indicators for July 2025. The company served a total of 76,544 customers, with sales per customer averaging JPY 7,389. The customer repeat ratio stood at 77.0%. In its Salon Operation Business, MEDIROM noted that the sales per customer remain high at ¥7,389, which is approximately ¥2,583 above the previous figures. In the Health Tech Business segment, which includes the Lav® on-demand training application, MEDIROM has entered into contracts with 101 corporate insurance associations. The cumulative number of users of the Lav® app has exceeded 10,000 people, totaling 10,842 individuals. This segment is expected to grow due to the increased adoption of Information and Communication Technology (ICT) in health guidance programs, partly driven by the impact of COVID-19. The company aims to meet the nationwide target set by Japan's Ministry of Health, Labor and Welfare for specific medical checkup and guidance implementation rates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001558370-25-011682), on August 20, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10